<p>Oglejte si serijo videoposnetkov z doc. dr. Novakom in doc. dr. Drobnetom o vplivu fekalne nuje (urgentnih pozivov na blato) na kakovost življenja pri bolnikih z ulceroznim kolitisom. Fekalna nuja, pogost in pogosto spregledan simptom, ki zaznamuje vse komponente kakovosti življenja, močno vpliva na delo, družabno življenje, telesno ter spolno aktivnost in duševno zdravje bolnikov. V podcastu zdravnika delita izkušnje iz ambulante in poudarjata nujnost naslavljanja tega simptoma.</p>

<p><a href="https://public.mediately.co/assets/wp-uploads/2024/05/24092637/Urgentni_pozivi_na_blato_simptom__o_katerem_ne_govorimo_PP-LG-SI-0017.pptx.pdf">Vsebino izobraževanja si lahko ogledate v predstavitvi.</a></p>

<p><a href="https://public.mediately.co/assets/wp-uploads/2024/05/24092928/Drobne_Kaj-vpliva-na-kakovos-zivljenja-pri-bolnikih-z-ulceroznim-kolitisom_SLO_PP-LG-SI-0016.pptx.pdf">Vsebino izobraževanja si lahko ogledate v predstavitvi.</a></p>

<ol>
<li>Dignass, Axel, et al. &#8220;Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis.&#8221; <i>Journal of Crohn&#8217;s and Colitis</i> 6.10 (2012): 965-990.</li>
<li>Nóbrega, Viviane Gomes, et al. &#8220;The onset of clinical manifestations in inflammatory bowel disease patients.&#8221; <i>Arquivos de gastroenterologia</i> 55 (2018): 290-295.</li>
<li>Perler, Bryce K., et al. &#8220;Presenting symptoms in inflammatory bowel disease: descriptive analysis of a community-based inception cohort.&#8221; <i>BMC gastroenterology</i> 19 (2019): 1-8.</li>
<li>Magro, Fernando, et al. &#8220;European Crohn’s and Colitis Organisation [ECCO]. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders.&#8221; <i>J Crohns Colitis</i> 11.6 (2017): 649-670.</li>
<li>Newton, Louise, et al. &#8220;A qualitative study exploring the health-related quality of life and symptomatic experiences of adults and adolescents with ulcerative colitis.&#8221; <i>Journal of patient-reported outcomes</i> 3 (2019): 1-13.</li>
<li>Sninsky, Jared A., et al. &#8220;Urgency and its association with quality of life and clinical outcomes in patients with ulcerative colitis.&#8221; <i>Official journal of the American College of Gastroenterology| ACG</i> 117.5 (2022): 769-776.</li>
<li>US Department of Health and Human Services [FDA Guidance for UC Endpoints] 2016. Available at: <a href="https://www.fda.gov/media/99526/download">https://www.fda.gov/media/99526/download</a></li>
<li>MedlinePlus. Available at: <a href="https://medlineplus.gov/ency/article/003131.htm">https://medlineplus.gov/ency/article/003131.htm</a></li>
<li>
<div class="gs_citr" tabindex="0">Hibi, Toshifumi, et al. &#8220;Ulcerative colitis: disease burden, impact on daily life, and reluctance to consult medical professionals: results from a Japanese internet survey.&#8221; <i>Inflammatory intestinal diseases</i> 5.1 (2020): 27-35.</div>
</li>
<li>
<div class="gs_citr" tabindex="0">Dubinsky, Marla C., et al. &#8220;Incorporating patient experience into drug development for ulcerative colitis: development of the Urgency Numeric Rating Scale, a patient-reported outcome measure to assess bowel urgency in adults.&#8221; <i>Journal of Patient-Reported Outcomes</i> 6.1 (2022): 31.</div>
</li>
<li>Teich, Niels, et al. &#8220;Novel approaches identifying relevant patient-reported outcomes in patients with inflammatory bowel diseases—LISTEN 1.&#8221; <i>Crohn&#8217;s &amp; Colitis 360</i> 3.3 (2021): otab050.</li>
<li>Rao, S. S., C. D. Holdsworth, and N. W. Read. &#8220;Symptoms and stool patterns in patients with ulcerative colitis.&#8221; <i>Gut</i> 29.3 (1988): 342-345.</li>
<li>Casanova, M. J., C. Santander, and J. P. Gisbert. &#8220;Rectal hypersensitivity in patients with quiescent ulcerative colitis.&#8221; <i>Journal of Crohn&#8217;s and Colitis</i> 9.7 (2015): 592-592.</li>
<li>Wolf DC, et al.P0396. <i data-stringify-type="italic">United European Gastroenterol J</i>. 2020;8(Suppl. 8):144-887.</li>
<li>Petryszyn, Paweł W., and Leszek Paradowski. &#8220;Stool patterns and symptoms of disordered anorectal function in patients with inflammatory bowel diseases.&#8221; <i>Advances in Clinical and Experimental Medicine</i> 27.6 (2018): 813-818.</li>
<li>
<div class="gs_citr" tabindex="0">Dawwas, Ghadeer K., et al. &#8220;Prevalence and factors associated with fecal urgency among patients with ulcerative colitis and Crohn’s disease in the study of a prospective adult research cohort with inflammatory bowel disease.&#8221; <i>Crohn&#8217;s &amp; Colitis 360</i> 3.3 (2021): otab046.</div>
</li>
<li>Kemp, Karen, et al. &#8220;Second N-ECCO consensus statements on the European nursing roles in caring for patients with Crohn’s disease or ulcerative colitis.&#8221; <i>Journal of Crohn&#8217;s and Colitis</i> 12.7 (2018): 760-776.</li>
<li>
<div class="gs_citr" tabindex="0">Rao, Satish SC. &#8220;Diagnosis and management of fecal incontinence.&#8221; <i>Official journal of the American College of Gastroenterology| ACG</i> 99.8 (2004): 1585-1604.</div>
</li>
<li>
<div class="gs_citr" tabindex="0">Dibley, Lesley, and Christine Norton. &#8220;Experiences of fecal incontinence in people with inflammatory bowel disease: self-reported experiences among a community sample.&#8221; <i>Inflammatory Bowel Diseases</i> 19.7 (2013): 1450-1462.</div>
</li>
<li>
<div class="gs_citr" tabindex="0">van Deen, Welmoed K., et al. &#8220;An assessment of symptom burden in inflammatory bowel diseases to develop a patient preference-weighted symptom score.&#8221; <i>Quality of Life Research</i> 29 (2020): 3387-3396.</div>
</li>
<li>Vaizey, C. J., et al. &#8220;Prospective comparison of faecal incontinence grading systems.&#8221; <i>Gut</i> 44.1 (1999): 77-80.</li>
<li>
<div class="gs_citr" tabindex="0">Nóbrega, Viviane Gomes, et al. &#8220;The onset of clinical manifestations in inflammatory bowel disease patients.&#8221; <i>Arquivos de gastroenterologia</i> 55 (2018): 290-295.</div>
</li>
<li>
<div class="gs_citr" tabindex="0">Teich, Niels, et al. &#8220;Novel approaches identifying relevant patient-reported outcomes in patients with inflammatory bowel diseases—LISTEN 1.&#8221; <i>Crohn&#8217;s &amp; Colitis 360</i> 3.3 (2021): otab050.</div>
</li>
<li>Dulai, Parambir S., et al. &#8220;Development of the symptoms and impacts questionnaire for Crohn&#8217;s disease and ulcerative colitis.&#8221; <i>Alimentary Pharmacology &amp; Therapeutics</i> 51.11 (2020): 1047-1066.</li>
<li>
<div class="gs_citr" tabindex="0">Ueno, Fumiaki, et al. &#8220;Impact of inflammatory bowel disease on Japanese patients’ quality of life: results of a patient questionnaire survey.&#8221; <i>Journal of Gastroenterology</i> 52 (2017): 555-567.</div>
</li>
<li>
<div class="gs_citr" tabindex="0">Lönnfors, Sanna, Severine Vermeire, and Luisa Avedano. &#8220;IBD and health-related quality of life—discovering the true impact.&#8221; <i>Journal of Crohn&#8217;s and Colitis</i> 8.10 (2014): 1281-1286.</div>
</li>
<li>
<div class="gs_citr" tabindex="0">Nag, Arpita, and Beverly Romero. &#8220;Development and content validation of patient-reported outcomes tools for ulcerative colitis and Crohn’s disease in adults with moderate-to-severe disease.&#8221; <i>Health and quality of life outcomes</i> 20.1 (2022): 75.</div>
</li>
<li>
<div class="gs_citr" tabindex="0">Gavaler, Judith S., et al. &#8220;Ulcerative colitis disease activity as subjectively assessed by patient-completed questionnaires following orthotopic liver transplantation for sclerosing cholangitis.&#8221; <i>Digestive diseases and sciences</i> 36 (1991): 321-328.</div>
</li>
<li>
<div class="gs_citr" tabindex="0">Fawson, Sophie, et al. &#8220;Developing an online program for self-management of fatigue, pain, and urgency in inflammatory bowel disease: Patients’ needs and wants.&#8221; <i>Digestive diseases and sciences</i> 67.7 (2022): 2813-2826.</div>
</li>
<li>Schreiber S, et al. Predstavitev na CCC 2022. Plakat P002.</li>
<li>
<div class="gs_citr" tabindex="0">Rao, S. S., C. D. Holdsworth, and N. W. Read. &#8220;Symptoms and stool patterns in patients with ulcerative colitis.&#8221; <i>Gut</i> 29.3 (1988): 342-345.</div>
</li>
<li>
<div class="gs_citr" tabindex="0">Rao, Satish Sanku Chander, et al. &#8220;Anorectal sensitivity and responses to rectal distention in patients with ulcerative colitis.&#8221; <i>Gastroenterology</i> 93.6 (1987): 1270-1275.</div>
</li>
<li>
<div class="gs_citr" tabindex="0">Drewes, Asbjφrn Mohr, et al. &#8220;Pain and mechanical properties of the rectum in patients with active ulcerative colitis.&#8221; <i>Inflammatory bowel diseases</i> 12.4 (2006): 294-303.</div>
</li>
<li>
<div class="gs_citr" tabindex="0">Limdi, Jimmy K., and Dipesh H. Vasant. &#8220;Anorectal dysfunction in distal ulcerative colitis: challenges and opportunities for topical therapy.&#8221; <i>Journal of Crohn&#8217;s and Colitis</i> 10.4 (2016): 503-503.</div>
</li>
<li>
<div class="gs_citr" tabindex="0">Gordon, Ilyssa O., et al. &#8220;Fibrosis in ulcerative colitis is directly linked to severity and chronicity of mucosal inflammation.&#8221; <i>Alimentary pharmacology &amp; therapeutics</i> 47.7 (2018): 922-939.</div>
</li>
<li>
<div class="gs_citr" tabindex="0">Casanova, M. J., C. Santander, and J. P. Gisbert. &#8220;Rectal hypersensitivity in patients with quiescent ulcerative colitis.&#8221; <i>Journal of Crohn&#8217;s and Colitis</i> 9.7 (2015): 592-592.</div>
</li>
<li>
<div class="gs_citr" tabindex="0">Cleveland, Noa Krugliak, et al. &#8220;A summary of the BRIDGe summit on damage-related progression of ulcerative colitis: establishing research priorities.&#8221; <i>Gastroenterology</i> 163.6 (2022): 1505-1509.</div>
</li>
<li>
<div class="gs_citr" tabindex="0">Cleveland, Noa Krugliak, Joana Torres, and David T. Rubin. &#8220;What does disease progression look like in ulcerative colitis, and how might it be prevented?.&#8221; <i>Gastroenterology</i> 162.5 (2022): 1396-1408.</div>
</li>
<li>
<div class="gs_citr" tabindex="0">Holtmann, Gerald J., Alexander C. Ford, and Nicholas J. Talley. &#8220;Pathophysiology of irritable bowel syndrome.&#8221; <i>The lancet Gastroenterology &amp; hepatology</i> 1.2 (2016): 133-146.</div>
</li>
<li>
<div class="gs_citr" tabindex="0">Papathanasopoulos, Athanasios A., et al. &#8220;Increased fatigability of external anal sphincter in inflammatory bowel disease: significance in fecal urgency and incontinence.&#8221; <i>Journal of Crohn&#8217;s and Colitis</i> 4.5 (2010): 553-560.</div>
</li>
<li>
<div class="gs_citr" tabindex="0">Higgins, Peter DR, et al. &#8220;Is endoscopy necessary for the measurement of disease activity in ulcerative colitis?.&#8221; <i>Official journal of the American College of Gastroenterology| ACG</i> 100.2 (2005): 355-361.</div>
</li>
<li>
<div class="gs_citr" tabindex="0">Sninsky, Jared A., et al. &#8220;Urgency and its association with quality of life and clinical outcomes in patients with ulcerative colitis.&#8221; <i>Official journal of the American College of Gastroenterology| ACG</i> 117.5 (2022): 769-776.</div>
</li>
<li>
<div class="gs_citr" tabindex="0">Tew, Garry A., Katherine Jones, and Antonina Mikocka-Walus. &#8220;Physical activity habits, limitations, and predictors in people with inflammatory bowel disease: a large cross-sectional online survey.&#8221; <i>Inflammatory bowel diseases</i> 22.12 (2016): 2933-2942.</div>
</li>
<li>
<div class="gs_citr" tabindex="0">Sninsky, Jared A., et al. &#8220;Urgency and its association with quality of life and clinical outcomes in patients with ulcerative colitis.&#8221; <i>Official journal of the American College of Gastroenterology| ACG</i> 117.5 (2022): 769-776.</div>
</li>
<li>
<div class="gs_citr" tabindex="0">Dibley, Lesley, and Christine Norton. &#8220;Experiences of fecal incontinence in people with inflammatory bowel disease: self-reported experiences among a community sample.&#8221; <i>Inflammatory Bowel Diseases</i> 19.7 (2013): 1450-1462.</div>
</li>
<li>
<div class="gs_citr" tabindex="0">Rasmussen, Bjørn, et al. &#8220;Predictors of health-related quality of life in patients with moderate to severely active ulcerative colitis receiving biological therapy.&#8221; <i>Scandinavian Journal of Gastroenterology</i> 55.6 (2020): 656-663.</div>
</li>
<li>
<div class="gs_citr" tabindex="0">Rubin, David T., et al. &#8220;International perspectives on management of inflammatory bowel disease: opinion differences and similarities between patients and physicians from the IBD GAPPS survey.&#8221; <i>Inflammatory bowel diseases</i> 27.12 (2021): 1942-1953.</div>
</li>
<li>
<div class="gs_citr" tabindex="0">Ueno, Fumiaki, et al. &#8220;Impact of inflammatory bowel disease on Japanese patients’ quality of life: results of a patient questionnaire survey.&#8221; <i>Journal of Gastroenterology</i> 52 (2017): 555-567.</div>
</li>
<li>
<div class="gs_citr" tabindex="0">Tew, Garry A., Katherine Jones, and Antonina Mikocka-Walus. &#8220;Physical activity habits, limitations, and predictors in people with inflammatory bowel disease: a large cross-sectional online survey.&#8221; <i>Inflammatory bowel diseases</i> 22.12 (2016): 2933-2942.</div>
</li>
<li>
<div class="gs_citr" tabindex="0">Dibley, Lesley, Christine Norton, and Elizabeth Whitehead. &#8220;The experience of stigma in inflammatory bowel disease: An interpretive (hermeneutic) phenomenological study.&#8221; <i>Journal of Advanced Nursing</i> 74.4 (2018): 838-851.</div>
</li>
<li>
<div class="gs_citr" tabindex="0">
<p>Waljee, Akbar K., et al. &#8220;Patient reported symptoms during an ulcerative colitis flare: a Qualitative Focus Group Study.&#8221; <i>European journal of gastroenterology &amp; hepatology</i> 21.5 (2009): 558-564.</p>
<div class="section">
<div class="layoutArea"></div>
</div>
</div>
</li>
<li>FDA. Ulcerative Colitis: Developing Drugs for Treatment Guidance for Industry. April 2022. Available at: <a href="https://www.fda.gov/media/158016/download">https://www.fda.gov/media/158016/download</a></li>
<li>
<div class="gs_citr" tabindex="0">Dubinsky, Marla C., et al. &#8220;Incorporating patient experience into drug development for ulcerative colitis: development of the Urgency Numeric Rating Scale, a patient-reported outcome measure to assess bowel urgency in adults.&#8221; <i>Journal of Patient-Reported Outcomes</i> 6.1 (2022): 31.</div>
</li>
<li>
<div class="gs_citr" tabindex="0">Carpio, Daniel, et al. &#8220;Perception of disease burden and treatment satisfaction in patients with ulcerative colitis from outpatient clinics in Spain: UC-LIFE survey.&#8221; <i>European journal of gastroenterology &amp; hepatology</i> 28.9 (2016): 1056-1064.</div>
</li>
<li>
<div class="gs_citr" tabindex="0">Travis, Simon PL, et al. &#8220;defining remission in ulcerative colitis.&#8221; <i>Alimentary pharmacology &amp; therapeutics</i> 34.2 (2011): 113-124.</div>
</li>
<li>
<div class="gs_citr" tabindex="0">Louis, Edouard, et al. &#8220;A qualitative research for defining meaningful attributes for the treatment of inflammatory bowel disease from the patient perspective.&#8221; <i>The Patient-Patient-Centered Outcomes Research</i> 13 (2020): 317-325.</div>
</li>
<li>
<div class="gs_citr" tabindex="0">van Deen, Welmoed K., et al. &#8220;An assessment of symptom burden in inflammatory bowel diseases to develop a patient preference-weighted symptom score.&#8221; <i>Quality of Life Research</i> 29 (2020): 3387-3396.</div>
</li>
<li>
<div class="gs_citr" tabindex="0">Lesnovska, Katarina Pihl, et al. &#8220;Critical situations in daily life as experienced by patients with inflammatory bowel disease.&#8221; <i>Gastroenterology Nursing</i> 39.3 (2016): 195-203.</div>
</li>
<li>
<div tabindex="0">
<div class="gs_citr" tabindex="0">Casellas, Francesc, et al. &#8220;Patient preferences for inflammatory bowel disease treatment objectives.&#8221; <i>Digestive and Liver Disease</i> 49.2 (2017): 152-156.</div>
</div>
</li>
<li>
<div class="gs_citr" tabindex="0">Rubin, David T., et al. &#8220;ACG clinical guideline: ulcerative colitis in adults.&#8221; <i>Official journal of the American College of Gastroenterology| ACG</i> 114.3 (2019): 384-413.</div>
</li>
<li>
<div class="gs_citr" tabindex="0">
<div class="gs_citr" tabindex="0">Travis, Simon, et al. &#8220;The communicating needs and features of IBD experiences (confide) study: US and European patient and health care professional perceptions of the experience and impact of symptoms of moderate-to-severe ulcerative colitis.&#8221; <i>Inflammatory Bowel Diseases</i> (2023): izad142.</div>
<div tabindex="0"></div>
<div tabindex="0"></div>
<div tabindex="0"></div>
<div tabindex="0"></div>
</div>
</li>
</ol>


Avtor/ji

Bodite na tekočem z novimi spoznanji na vašem področju

Reference

Uporabite Mediately aplikacijo

Uporabite Mediately aplikacijo